Veritaseum (VERI) Hits 24-Hour Volume of $996,079.00

Veritaseum (CURRENCY:VERI) traded down 1.3% against the dollar during the twenty-four hour period ending at 21:00 PM Eastern on March 24th. In the last week, Veritaseum has traded up 105.3% against the dollar. Veritaseum has a market capitalization of $431.63 million and $996,079.00 worth of Veritaseum was traded on exchanges in the last 24 hours. One Veritaseum token can now be bought for $211.93 or 0.02476300 BTC on major exchanges including Token Store, Mercatox, EtherDelta and HitBTC.

Here’s how related cryptocurrencies have performed in the last 24 hours:

How to Become a New Pot Stock Millionaire
  • Ripple (XRP) traded down 3.5% against the dollar and now trades at $0.64 or 0.00007475 BTC.
  • Stellar (XLM) traded down 1.4% against the dollar and now trades at $0.24 or 0.00002751 BTC.
  • NEO (NEO) traded 5.6% lower against the dollar and now trades at $65.41 or 0.00764328 BTC.
  • IOTA (MIOTA) traded 3.1% lower against the dollar and now trades at $1.32 or 0.00015410 BTC.
  • TRON (TRX) traded 17.1% higher against the dollar and now trades at $0.0495 or 0.00000578 BTC.
  • Tether (USDT) traded down 0% against the dollar and now trades at $1.00 or 0.00011683 BTC.
  • VeChain (VEN) traded down 3.3% against the dollar and now trades at $3.32 or 0.00038796 BTC.
  • Binance Coin (BNB) traded 8.4% higher against the dollar and now trades at $13.20 or 0.00154190 BTC.
  • Populous (PPT) traded 0.1% lower against the dollar and now trades at $15.39 or 0.00179806 BTC.
  • Walton (WTC) traded up 7.9% against the dollar and now trades at $22.77 or 0.00246724 BTC.

Veritaseum Profile

Veritaseum was first traded on April 25th, 2017. Veritaseum’s total supply is 100,000,000 tokens and its circulating supply is 2,036,645 tokens. Veritaseum’s official website is veritas.veritaseum.com. Veritaseum’s official Twitter account is @Veritaseuminc and its Facebook page is accessible here.

According to CryptoCompare, “Veritaseum is a smart contract-based wallet interface that allows anyone to create, enter and manage smart contracts without the need for any kind of intermediaries, middleman or centralized authority.¬† Veritaseum will allow users to interact with real-world products¬†based completely on blockchain technology and smart contracts, including P2P value trading, P2P letters of credit and DAOs. VERI tokens will allow users to interact with the Veritaseum wallet interface. “

Buying and Selling Veritaseum

Veritaseum can be bought or sold on these cryptocurrency exchanges: EtherDelta, HitBTC, Mercatox and Token Store. It is not possible to purchase Veritaseum directly using US dollars. Investors seeking to acquire Veritaseum must first purchase Bitcoin or Ethereum using an exchange that deals in US dollars such as Changelly, Gemini or Coinbase. Investors can then use their newly-acquired Bitcoin or Ethereum to purchase Veritaseum using one of the aforementioned exchanges.

new TradingView.widget({ “height”: 400, “width”: 650, “symbol”: “VERIUSD”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Receive News & Updates for Veritaseum Daily - Enter your email address below to receive a concise daily summary of the latest news and updates for Veritaseum and related cryptocurrencies with MarketBeat.com's FREE CryptoBeat newsletter.

Latest News

MKS Instruments  Stock Price Down 9.4%
MKS Instruments Stock Price Down 9.4%
Gold Fields  Shares Gap Up to $3.92
Gold Fields Shares Gap Up to $3.92
Analysts Expect Sally Beauty Holdings  Will Post Earnings of $0.55 Per Share
Analysts Expect Sally Beauty Holdings Will Post Earnings of $0.55 Per Share
Zacks: Brokerages Anticipate Financial Institutions, Inc.  to Post $0.55 Earnings Per Share
Zacks: Brokerages Anticipate Financial Institutions, Inc. to Post $0.55 Earnings Per Share
RTI Surgical  Lowered to Sell at BidaskClub
RTI Surgical Lowered to Sell at BidaskClub
Ovid Therapeutics  Earns Buy Rating from Analysts at Ladenburg Thalmann
Ovid Therapeutics Earns Buy Rating from Analysts at Ladenburg Thalmann


© 2006-2018 Ticker Report. Google+.